IL-1 is required for angiogenesis and invasiveness as mice deficient in IL-1alpha or IL-1beta exhibit impaired tumor development and blood vessel growth in melanoma, mammary adenocarcinoma, and prostate cancer (Voronov et al., 2003). The gene discussed is IL1B; the disease is prostate carcinoma.